share_log

騰盛博藥-B：(1)建議採納經審核合併財務報表；(2)重選退任董事；(3)續聘核數師；(4)發行及購回股份之一般授權；及(5)股東週年大會通告

BRII-B: (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AND (5) NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 25 04:40
Summary by Moomoo AI
腾盛博药-B（Brii Biosciences Limited）將於2024年6月25日透過卓佳電子會議系統舉行股東週年大會，討論事項包括採納經審核合併財務報表、重選退任董事、續聘核數師、發行及購回股份之一般授權等。公司已於2024年4月26日向股東發出通函，並附上代表委任表格。股東若無法出席，需於2024年6月23日前提交代表委任表格。此外，公司將於2024年6月20日至25日暫停股份過戶登記手續，以釐定出席及投票資格。股東週年大會的所有決議案將以投票方式表決。
腾盛博药-B（Brii Biosciences Limited）將於2024年6月25日透過卓佳電子會議系統舉行股東週年大會，討論事項包括採納經審核合併財務報表、重選退任董事、續聘核數師、發行及購回股份之一般授權等。公司已於2024年4月26日向股東發出通函，並附上代表委任表格。股東若無法出席，需於2024年6月23日前提交代表委任表格。此外，公司將於2024年6月20日至25日暫停股份過戶登記手續，以釐定出席及投票資格。股東週年大會的所有決議案將以投票方式表決。
Brii Biosciences Limited will hold its Annual General Meeting on June 25, 2024 via Superior Electronic Conferencing System to discuss issues including adoption of audited consolidated financial statements, re-election of retiring directors, renewal of auditors, general mandates to issue and repurchase shares, etc. The Company has issued a circular to shareholders on 26 April 2024, accompanied by a proxy form. If shareholders are unable to attend, the proxy form must be submitted by 23 June 2024. In addition, the Company will suspend the registration of shares from 20 to 25 June 2024 in order to determine attendance and voting eligibility. All resolutions of the Annual General Meeting will be voted on by vote.
Brii Biosciences Limited will hold its Annual General Meeting on June 25, 2024 via Superior Electronic Conferencing System to discuss issues including adoption of audited consolidated financial statements, re-election of retiring directors, renewal of auditors, general mandates to issue and repurchase shares, etc. The Company has issued a circular to shareholders on 26 April 2024, accompanied by a proxy form. If shareholders are unable to attend, the proxy form must be submitted by 23 June 2024. In addition, the Company will suspend the registration of shares from 20 to 25 June 2024 in order to determine attendance and voting eligibility. All resolutions of the Annual General Meeting will be voted on by vote.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more